Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer-Reference-Cited by-同舟云学术

Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer

Published:2019-08 Issue: Volume:46 Page:25-31
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Zdenkowski Nicholas,Butow Phyllis,Spillane Andrew,Douglas Charles,Snook Kylie,Jones Mark,Oldmeadow Christopher,Fewster Sheryl,Beckmore Corinna,Boyle Frances M.

Funder

HCF Research Foundation

Hunter New England Local Health District

Friends of the Mater Foundation

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference29 articles.

1. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States;Mougalian;Cancer,2015

2. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017;Curigliano;Ann Oncol,2017

3. NCCN clinical practice guidelines in oncology;National Comprehensive Cancer Network,2017

4. Diagnosis and treatment of patients with primary and metastatic breast cancer;Onkologie,2017

5. Decision support for patients: values clarification and preference elicitation;Llewellyn-Thomas;Med Care Res Rev,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of psychological distress instruments in women with early‐stage breast cancer during chemotherapy;Cancer Reports;2023-05-12

2. Adjuvant vs. neoadjuvant chemotherapy: quality of life and psychosocial variables in women with breast cancer;Health Psychology Report;2022-10-05

3. Spotlight on the Fear of Cancer Recurrence Inventory (FCRI);Psychology Research and Behavior Management;2020-12

4. Évaluation de la satisfaction de patientes atteintes d’un cancer du sein précoce traitées en adjuvant par hormonothérapie;Bulletin du Cancer;2019-12